Melissa Loh, Associate Professor at the University of Rochester Medical Center, shared on X:
“Extension of our prior work on healthcare utilization in leukaemia and myelodysplastic syndrome, we now also showed high cost at EOL.
MOLST form completion associated with lower cost.”
Authors: Marissa LoCastro, Andrea M. Baran, Jane L. Liesveld, Eric Huselton, Michael W. Becker, Kristen Marie O’Dwyer, Omar S. Aljitawi, Megan Baumgart, Eric Snyder, Benzi Kluger, Kah Poh Loh, Jason H. Mendler
